Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS

Neuroscience

Volumn 291, Issue , 2015, Pages 216-229

  Comley, L ^a   Allodi, I ^a   Nichterwitz, S ^a   Nizzardo, M ^b   Simone, C ^b   Corti, S ^b   Hedlund, E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Motor neuron; Neurodegeneration; Oculomotor; Selective vulnerability

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA2; DYNEIN ADENOSINE TRIPHOSPHATASE; GUANYLATE CYCLASE; GUANYLATE CYCLASE SOLUBLE SUBUNIT ALPHA 3; PARVALBUMIN; PERIPHERIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOGLOSSAL NERVE; MALE; MIDDLE AGED; MOTONEURON; MOUSE; NERVE DEGENERATION; NONHUMAN; OCULOMOTOR NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD MOTONEURON; TRANSGENIC MOUSE; VERY ELDERLY; ANIMAL; ANTERIOR HORN CELL; BRAIN STEM; C57BL MOUSE; CELL COUNT; COMPARATIVE STUDY; DISEASE MODEL; METABOLISM; PATHOLOGY;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTERIOR HORN CELLS; BRAIN STEM; CELL COUNT; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; MOTOR NEURONS; NERVE DEGENERATION;

EID: 84923329869     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.02.013     Document Type: Article

References (39)

1. Al-Chalabi A., Jones A., Troakes C., King A., Al-Sarraj S., et al. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 2012, 124:339-352.
2. Beaulieu J.M., Nguyen M.D., Julien J.P. Late onset of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol 1999, 147:531-544.
3. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006, 312:1389-1392.
4. Brockington A., Ning K., Heath P.R., Wood E., Kirby J., et al. Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol 2013, 125:95-109.
5. Chang Q., Martin L.J. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 2011, 31:2815-2827.
6. Collard J.F., Cote F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 1995, 375:61-64.
7. Das M.M., Svendsen C.N. Astrocytes show reduced support of motor neurons with aging that is accelerated in a rodent model of ALS. Neurobiol Aging 2014.
8. Dekkers J., Bayley P., Dick J.R., Schwaller B., Berchtold M.W., et al. Over-expression of parvalbumin in transgenic mice rescues motoneurons from injury-induced cell death. Neuroscience 2004, 123:459-466.
9. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004, 185:232-240.
10. Gizzi M., DiRocco A., Sivak M., Cohen B. Ocular motor function in motor neuron disease. Neurology 1992, 42:1037-1046.
11. Gurney M.E. Transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med 1994, 331:1721-1722.
12. Haenggeli C., Kato A.C. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci Lett 2002, 335:39-43.
13. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003, 300:808-812.
14. He C.Z., Hays A.P. Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis. J Neurol Sci 2004, 217:47-54.
15. Hedlund E., Karlsson M., Osborn T., Ludwig W., Isacson O. Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection. Brain 2010, 133:2313-2330.
16. Huang C., Tong J., Bi F., Zhou H., Xia X.G. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J Clin Invest 2012, 122:107-118.
17. Jaarsma D., Teuling E., Haasdijk E.D., De Zeeuw C.I., Hoogenraad C.C. Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J Neurosci 2008, 28:2075-2088.
18. Jiang Y.M., Yamamoto M., Tanaka F., Ishigaki S., Katsuno M., et al. Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2007, 66:617-627.
19. Kaplan A., Spiller K.J., Towne C., Kanning K.C., Choe G.T., et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron 2014, 81:333-348.
20. Kieran D., Hafezparast M., Bohnert S., Dick J.R., Martin J., et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 2005, 169:561-567.
21. Kiskinis E., Sandoe J., Williams L.A., Boulting G.L., Moccia R., et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 2014, 14:781-795.
22. Kubota M., Sakakihara Y., Uchiyama Y., Nara A., Nagata T., et al. New ocular movement detector system as a communication tool in ventilator-assisted Werdnig-Hoffmann disease. Dev Med Child Neurol 2000, 42:61-64.
23. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002, 34:715-727.
24. Laslo P., Lipski J., Nicholson L.F., Miles G.B., Funk G.D. Calcium binding proteins in motoneurons at low and high risk for degeneration in ALS. NeuroReport 2000, 11:3305-3308.
25. Leung C.L., He C.Z., Kaufmann P., Chin S.S., Naini A., et al. A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol 2004, 14:290-296.
26. Lorenzo L.E., Barbe A., Portalier P., Fritschy J.M., Bras H. Differential expression of GABAA and glycine receptors in ALS-resistant vs. ALS-vulnerable motoneurons: possible implications for selective vulnerability of motoneurons. Eur J Neurosci 2006, 23:3161-3170.
27. Millecamps S., Robertson J., Lariviere R., Mallet J., Julien J.P. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin. J Neurochem 2006, 98:926-938.
28. Nimchinsky E.A., Young W.G., Yeung G., Shah R.A., Gordon J.W., et al. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J Comp Neurol 2000, 416:112-125.
29. Saxena S., Cabuy E., Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 2009, 12:627-636.
30. Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 2005, 490:209-219.
31. Shaw C.E., Enayat Z.E., Powell J.F., Anderson V.E., Radunovic A., et al. Familial amyotrophic lateral sclerosis. Molecular pathology of a patient with a SOD1 mutation. Neurology 1997, 49:1612-1616.
32. Tanaka F., Ikenaka K., Yamamoto M., Sobue G. Neuropathology and omics in motor neuron diseases. Neuropathology 2012, 32:458-462.
33. Tjust A.E., Brannstrom T., Pedrosa Domellof F. Unaffected motor endplate occupancy in eye muscles of ALS G93A mouse model. Front Biosci (Schol Ed) 2012, 4:1547-1555.
34. Van Den Bosch L., Schwaller B., Vleminckx V., Meijers B., Stork S., et al. Protective effect of parvalbumin on excitotoxic motor neuron death. Exp Neurol 2002, 174:150-161.
35. van Zundert B., Peuscher M.H., Hynynen M., Chen A., Neve R.L., et al. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 2008, 28:10864-10874.
36. Waters J.C. Accuracy and precision in quantitative fluorescence microscopy. J Cell Biol 2009, 185:1135-1148.
37. Xiao S., Tjostheim S., Sanelli T., McLean J.R., Horne P., et al. An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology. J Neurosci 2008, 28:1833-1840.
38. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008, 11:251-253.
39. Zabel U., Weeger M., La M., Schmidt H.H. Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem J 1998, 335(Pt. 1):51-57.